You're reading the free version. Trader adds the live tape and alerts.
Start tracking
CRNX Disposition Disclosure
Kalofonos Isabel · SEC Form 4 · Filed Sep 1, 2026
Disposition
Calculated transaction value
$2.27M
Kalofonos Isabel Chief Commercial Officer
CRNX
Transaction date
Sep 1, 2026
Public filing date
Sep 1, 2026
Filing lag
Filed same day
CRNX daily price context
Close on/before transaction
$84.95
Sep 1, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 55,000 shares @ $41.21
- SEC ownership
- Direct
- Transaction code
- D
- Form
- 4
- Filing identifier
- 0001628280-26-059885
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$9.63M
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Crinetics Pharmaceuticals, Inc. CRNX | Disposition | Sep 1, 2026 | $141.87K |
| Crinetics Pharmaceuticals, Inc. CRNX | Disposition | Sep 1, 2026 | $2.89M |
| Crinetics Pharmaceuticals, Inc. CRNX | Disposition | Sep 1, 2026 | $4.33M |
| Crinetics Pharmaceuticals, Inc. CRNX Current | Disposition | Sep 1, 2026 | $2.27M |